Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index; 1 of the 15 sources its claims cite were checked for support.
Abstract
BACKGROUND: The embryonic stem cell (ESC) factor, SALL4, plays an essential role in both development and leukemogenesis. It is a unique gene that is involved in self-renewal in ESC and leukemic stem cell (LSC). METHODOLOGY/PRINCIPAL FINDINGS: To understand the mechanism(s) of SALL4 function(s), we sought to identify SALL4-associated proteins by tandem mass spectrometry. Components of a transcription repressor Mi-2/Nucleosome Remodeling and Deacetylase (NuRD) complex were found in the SALL4-immunocomplexes with histone deacetylase (HDAC) activity in ESCs with endogenous SALL4 expression and 293T cells overexpressing SALL4. The SALL4-mediated transcriptional regulation was tested on two potential target genes: PTEN and SALL1. Both genes were confirmed as SALL4 downstream targets by chromatin-immunoprecipitation, and their expression levels, when tested by quantitative reverse transcription polymerase chain reaction (qRT-PCR), were decreased in 293T cells overexpressing SALL4. Moreover, SALL4 binding sites at the promoter regions of PTEN and SALL1 were co-occupied by NuRD components, suggesting that SALL4 represses the transcriptions of PTEN and SALL1 through its interactions with the Mi-2/NuRD complex. The in vivo repressive effect(s) of SALL4 were evaluated in SALL4 transgenic mice, where decreased expressions of PTEN and SALL1 were associated with myeloid leukemia and cystic kidneys, respectively. CONCLUSIONS/SIGNIFICANCE: In summary, we are the first to demonstrate that stem cell protein SALL4 represses its target genes, PTEN and SALL1, through the epigenetic repressor Mi-2/NuRD complex. Our novel finding provides insight into the mechanism(s) of SALL4 functions in kidney development and leukemogenesis.
Overview
CoChat Summary
## TL;DR
SALL4 is shown to function as a strong transcriptional repressor by associating with the Mi-2/NuRD epigenetic repressor complex. The paper identifies PTEN and SALL1 as direct SALL4 targets whose expression is reduced in cells and in SALL4B transgenic mice.
## Key findings
- SALL4A and SALL4B localized to the nucleus in 293T cells, and a GAL4–SALL4B fusion repressed reporter transcription in a dose-dependent manner.
- Mass spectrometry of SALL4B immunocomplexes identified NuRD components, including Mi-2β, MTA1, MTA2, p66, HDAC1, and RbAP46; co-immunoprecipitation also detected HDAC2 and RbAP48, while Sin3A was not detected.
- SALL4-containing complexes had HDAC activity: exogenous SALL4A/SALL4B complexes showed 2- to 5-fold higher activity than IgG controls, and endogenous SALL4 complexes in ES cells showed a 2-fold increase; TSA reduced this activity.
- SALL4 bound PTEN and SALL1 promoter regions, and qRT-PCR showed reduced expression in 293T cells overexpressing SALL4A or SALL4B: PTEN decreased by 30% and 30%, and SALL1 decreased by 35% and 50%, respectively.
- In SALL4B transgenic mice, 50% developed cystic kidneys; SALL1 mRNA in kidneys decreased to 45% of wild-type controls, and PTEN mRNA in bone marrow decreased by 20% versus littermate controls.
## Methods
- The study combined protein purification/mass spectrometry, co-immunoprecipitation, HDAC assays, ChIP/qPCR, qRT-PCR, reporter assays, and mouse phenotyping/MRI/H&E staining.
- Main experimental systems were 293T cells, D3 mouse embryonic stem cells, and SALL4B transgenic mice; ChIP-on-chip in human CD34+ cells, NB4 cells, and human ESCs is mentioned as the source of candidate target genes.
- Analyses included promoter occupancy by SALL4 and NuRD components, transcript quantification relative to GAPDH, and comparison with input or control pull-downs.
## Limitations
- The paper does not report sample sizes for several experiments, so statistical robustness is hard to assess from the text alone.
- Some evidence is based on overexpression systems in 293T cells, which the text itself implies may not fully reflect endogenous regulation in native tissues.
- The paper states that further studies are needed to define how SALL4 switches between activating and repressing targets.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
1 Valid · 0 Not valid · 13 Not checked · 30 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“when both exogenous and endogenous SALL4-interacting protein complexes were incubated with trichostatin A (TSA), a histone deacetylase specific inhibitor, the HDAC activity was dramatically reduced.”
§ Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex > Results > SALL4-bound protein complex has histone deacetylase (HDAC) activity
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“both exogenous SALL4A and SALL4B-containing protein complexes exhibited 2 to 5 fold higher HDAC activity than the IgG control pull-down samples.”
- Also stated in: § SALL4-bound protein complex has histone deacetylase (HDAC) activity · plain
“a 2-fold increase in HDAC activity was observed in endogenous SALL4- associated protein complex in ES cells in comparison to the control.”
§ Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex > Results > SALL4-bound protein complex has histone deacetylase (HDAC) activity
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § SALL4-bound protein complex has histone deacetylase (HDAC) activity · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“2 to 5 fold enrichment was detected at the SALL4 binding sites of PTEN and SALL1 promoters when compared with input. However, there was no enrichment observed in the non-binding sites of both genes”
- Also stated in: § SALL4 and Mi-2/NuRD complex co-occupy the same genomic binding sites at the promoter regions of PTEN and SALL1 As shown above, SALL4 associates with the Mi-2/NuRD complex that is known to be involved in transcriptional repression. Thus, we propose that SALL4 represses the expression of PTEN and SALL1 via the NuRD complex. To test this hypothesis, we performed ChIP-qPCR analysis using the anti-HDAC2 antibody and examined whether HDAC2 and SALL4 shared the same binding site(s) at the promoters of PTEN and SALL1. We have shown that SALL4 binds to the specific promoter regions of PTEN (−2629 bp∼−2383 bp, Region I, and −1706 bp∼−1571 bp, Region III) and SALL1 (−2057 bp∼−1867 bp, Region II, and −1464 bp∼−1279 bp, Region V). In this experiment, in HDAC2 pulldown fragments of both SALL4A and SALL4B transfected cells, 2 to 5 fold enrichment was detected at the SALL4 binding sites of PTEN and SALL1 promoters when compared with input. However, there was no enrichment observed in the non-binding sites of both genes (Figure 5C & 6C). The same result was obtained from the ChIP-qPCR assay using anti-MTA2 antibody (data not shown). Therefore, these results illustrate that SALL4 and NuRD complex co-occupy the same promoter sites of PTEN and SALL1 and indicate that SALL4 downregulates the transcription of those two genes through histone deacetylation. In addition, we performed the same analysis using anti-acetyl Histone H3 antibody. This analysis showed when SALL4 was overexpressed the enrichment at SALL4-binding sites of PTEN and SALL1 was decreased from 35% to 83% respectively (Figure 5D & 6D), which suggested that there was reduced acetylation of histones H3 at these binding regions. These results strengthen the notion that SALL4-NuRD protein complex suppresses the expressions of PTEN and SALL1, the two SALL4 direct downstream target genes, by deacetylating the histones at their promoter regions. · plain
“these results illustrate that SALL4 and NuRD complex co-occupy the same promoter sites of PTEN and SALL1”
§ Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex > Results > SALL4 and Mi-2/NuRD complex co-occupy the same genomic binding sites at the promoter regions of PTEN and SALL1 As shown above, SALL4 associates with the Mi-2/NuRD complex that is known to be involved in transcriptional repression. Thus, we propose that SALL4 represses the expression of PTEN and SALL1 via the NuRD complex. To test this hypothesis, we performed ChIP-qPCR analysis using the anti-HDAC2 antibody and examined whether HDAC2 and SALL4 shared the same binding site(s) at the promoters of PTEN and SALL1. We have shown that SALL4 binds to the specific promoter regions of PTEN (−2629 bp∼−2383 bp, Region I, and −1706 bp∼−1571 bp, Region III) and SALL1 (−2057 bp∼−1867 bp, Region II, and −1464 bp∼−1279 bp, Region V). In this experiment, in HDAC2 pulldown fragments of both SALL4A and SALL4B transfected cells, 2 to 5 fold enrichment was detected at the SALL4 binding sites of PTEN and SALL1 promoters when compared with input. However, there was no enrichment observed in the non-binding sites of both genes (Figure 5C & 6C). The same result was obtained from the ChIP-qPCR assay using anti-MTA2 antibody (data not shown). Therefore, these results illustrate that SALL4 and NuRD complex co-occupy the same promoter sites of PTEN and SALL1 and indicate that SALL4 downregulates the transcription of those two genes through histone deacetylation. In addition, we performed the same analysis using anti-acetyl Histone H3 antibody. This analysis showed when SALL4 was overexpressed the enrichment at SALL4-binding sites of PTEN and SALL1 was decreased from 35% to 83% respectively (Figure 5D & 6D), which suggested that there was reduced acetylation of histones H3 at these binding regions. These results strengthen the notion that SALL4-NuRD protein complex suppresses the expressions of PTEN and SALL1, the two SALL4 direct downstream target genes, by deacetylating the histones at their promoter regions.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § SALL4 and Mi-2/NuRD complex co-occupy the same genomic binding sites at the promoter regions of PTEN and SALL1 As shown above, SALL4 associates with the Mi-2/NuRD complex that is known to be involved in transcriptional repression. Thus, we propose that SALL4 represses the expression of PTEN and SALL1 via the NuRD complex. To test this hypothesis, we performed ChIP-qPCR analysis using the anti-HDAC2 antibody and examined whether HDAC2 and SALL4 shared the same binding site(s) at the promoters of PTEN and SALL1. We have shown that SALL4 binds to the specific promoter regions of PTEN (−2629 bp∼−2383 bp, Region I, and −1706 bp∼−1571 bp, Region III) and SALL1 (−2057 bp∼−1867 bp, Region II, and −1464 bp∼−1279 bp, Region V). In this experiment, in HDAC2 pulldown fragments of both SALL4A and SALL4B transfected cells, 2 to 5 fold enrichment was detected at the SALL4 binding sites of PTEN and SALL1 promoters when compared with input. However, there was no enrichment observed in the non-binding sites of both genes (Figure 5C & 6C). The same result was obtained from the ChIP-qPCR assay using anti-MTA2 antibody (data not shown). Therefore, these results illustrate that SALL4 and NuRD complex co-occupy the same promoter sites of PTEN and SALL1 and indicate that SALL4 downregulates the transcription of those two genes through histone deacetylation. In addition, we performed the same analysis using anti-acetyl Histone H3 antibody. This analysis showed when SALL4 was overexpressed the enrichment at SALL4-binding sites of PTEN and SALL1 was decreased from 35% to 83% respectively (Figure 5D & 6D), which suggested that there was reduced acetylation of histones H3 at these binding regions. These results strengthen the notion that SALL4-NuRD protein complex suppresses the expressions of PTEN and SALL1, the two SALL4 direct downstream target genes, by deacetylating the histones at their promoter regions. · plain
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, SALL4A and SALL4B exhibited different binding sites at the promoter regions of PTEN and SALL1.”
§ Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex > Results > SALL4 binds to the promoter regions of PTEN and SALL1 and represses their expression in vitro To determine the molecular mechanism(s) of SALL4 in normal hematopoiesis, leukemogenesis and ESC development, we have mapped SALL4 global gene targets using chromatin-immunoprecipitation followed by microarray hybridization (ChIP-on-chip) in normal human CD34+ bone marrow cells, myeloid leukemic NB4 cells and human ESCs. Two genes that have been implicated in ESC, kidney development and leukemogenesis, PTEN and SALL1, were identified as potential SALL4 downstream target genes. We then sought to validate whether SALL4 binds to the promoter regions of these two genes using regular ChIP coupled with qPCR. Chromatin from 293T cells expressing either SALL4A or SALL4B was prepared, sonicated and immunoprecipitated with a rabbit polyclonal antibody against SALL4. QPCR was carried out with a series of primers specific for PTEN and SALL1 promoters, which were designed based on ChIP-on-chip results and covered possible SALL4 binding sites and adjacent non-binding sequences (Figure 5A & 6A). We observed a 2–3 fold enrichment in SALL4 pull-down at its binding site in the PTEN and SALL1 promoters when compared to input (no antibody added), while there was no enrichment at the non-binding sites (Figure 5B and 6B). We also observed that SALL4 was able to bind the promoter regions of these two genes in either mouse ESCs, two human AML samples including M0 (FAB classification) or AML transformed from CML (chronic myeloid leukemia) using ChIP-on-ChIP assays (data not shown). Interestingly, SALL4A and SALL4B exhibited different binding sites at the promoter regions of PTEN and SALL1. This could be due to the differences between the two isoforms in DNA binding zinc finger domains. While both SALL4A and SALL4B share the same N- and C-terminal domains, SALL4A has eight zinc finger domains, and SALL4B has only three. This structural variation may result in different binding affinity of SALL4A and SALL4B to the DNA and may explain why their binding sites at the promoters of PTEN and SALL1 are not identical.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the expression level of PTEN and SALL1 in SALL4A-expressed cells was decreased by 30% and 35%, respectively.”
§ Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex > Results > SALL4 binds to the promoter regions of PTEN and SALL1 and represses their expression in vitro To determine the molecular mechanism(s) of SALL4 in normal hematopoiesis, leukemogenesis and ESC development, we have mapped SALL4 global gene targets using chromatin-immunoprecipitation followed by microarray hybridization (ChIP-on-chip) in normal human CD34+ bone marrow cells, myeloid leukemic NB4 cells and human ESCs. Two genes that have been implicated in ESC, kidney development and leukemogenesis, PTEN and SALL1, were identified as potential SALL4 downstream target genes. We then sought to validate whether SALL4 binds to the promoter regions of these two genes using regular ChIP coupled with qPCR. Chromatin from 293T cells expressing either SALL4A or SALL4B was prepared, sonicated and immunoprecipitated with a rabbit polyclonal antibody against SALL4. QPCR was carried out with a series of primers specific for PTEN and SALL1 promoters, which were designed based on ChIP-on-chip results and covered possible SALL4 binding sites and adjacent non-binding sequences (Figure 5A & 6A). We observed a 2–3 fold enrichment in SALL4 pull-down at its binding site in the PTEN and SALL1 promoters when compared to input (no antibody added), while there was no enrichment at the non-binding sites (Figure 5B and 6B). We also observed that SALL4 was able to bind the promoter regions of these two genes in either mouse ESCs, two human AML samples including M0 (FAB classification) or AML transformed from CML (chronic myeloid leukemia) using ChIP-on-ChIP assays (data not shown). Interestingly, SALL4A and SALL4B exhibited different binding sites at the promoter regions of PTEN and SALL1. This could be due to the differences between the two isoforms in DNA binding zinc finger domains. While both SALL4A and SALL4B share the same N- and C-terminal domains, SALL4A has eight zinc finger domains, and SALL4B has only three. This structural variation may result in different binding affinity of SALL4A and SALL4B to the DNA and may explain why their binding sites at the promoters of PTEN and SALL1 are not identical.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
19 more claims
Create a free account to see all 44 claims and every source verdict.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“based on tandem mass spectrometry studies on ESCs and 293 T cells overexpressing SALL4, it has been shown that SALL4 can also bind to the NuRD complex members HDAC1 and HDAC245”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Phenotypically, the decreased expression of the tumor suppressor PTEN in SALL4 transgenic mice was associated with myeloid leukemia and cystic kidneys45.”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Spalt-like (SALL) proteins are C2H2 zinc-finger transcription factors important for embryogenesis”
From Tetramerisation governs SALL transcription factor function in development and disease (2025) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“One type of epigenetic enzymes that has been shown to interact with SALL4 are histone deacetylases (HDACs), specifically HDAC1 and HDAC228,44,45”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [45]
Citations
Cites
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361 · cited 1×
“This unique epigenetic state is essential for ESC pluripotency [49,50].”
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
Park, I.-K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., & Clarke, M. F. (2003) · Nature · doi:10.1038/nature01587 · Cited by 1,871 · cited 1×
“In addition, we have shown that constitutive expression of SALL4 contributes to leukemogenesis in adult mice by activating Bmi-1 [42], a key regulator in hematopoietic stem cells (HSCs) and leukemic stem cells (LSCs) [43].”
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention
Zhang, J., Grindley, J. C., Yin, T., Jayasinghe, S., He, X. C., Ross, J. T., Haug, J. S., Rupp, D., Porter-Westpfahl, K. S., Wiedemann, L. M., et al. (2006) · Nature · doi:10.1038/nature04747 · Cited by 817 · cited 2×
“PTEN is a tumor suppressor gene and essential for both normal hematopoiesis and leukemogenesis [28–30].”
ATP-Dependent Nucleosome Remodeling
Becker, P. B., & Hörz, W. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135400 · Cited by 789 · cited 1×
“It plays roles in transcriptional repression through its association with sequence specific DNA-binding protein in ESC, development, hematopoietic differentiation and tumorigenesis [25,26,45–47].”
Zhang, J., Tam, W.-L., Tong, G. Q., Wu, Q., Chan, H.-Y., Soh, B.-S., Lou, Y., Yang, J., Ma, Y., Chai, L., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1481 · Cited by 568 · cited 1×
“SALL4 is also essential for maintenance of pluripotent and self-renewal properties of embryonic stem cells (ESCs) by interacting with other two key regulators in ESCs, NANOG and OCT4 [16–19].”
Self-citationThe deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07290 · Cited by 548
Signalling through Class I PI3Ks in mammalian cells
Hawkins, P. T., Anderson, K. E., Davidson, K., & Stephens, L. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340647 · Cited by 540 · cited 1×
“Absence of PTEN can also alter ESC properties and impair kidney development [33–35].”
The human Mi-2/NuRD complex and gene regulation
Denslow, S. A., & Wade, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210611 · Cited by 478 · cited 1×
“Therefore, histone deacetylation and chromation remodeling ATPase activities are uniquely linked in this single protein complex Mi-2/NuRD, whose function is to produce compactly packed, hypoacetylated nucleosomes that switch an active, hyperacetylate promoter to its inactivated state [26].”
Ahringer, J. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02066-7 · Cited by 388 · cited 1×
“In contrast, deacetylated histones lead to condensed heterochromatin and repressed gene expression [25].”
Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development
Nishinakamura, R., Matsumoto, Y., Nakao, K., Nakamura, K., Sato, A., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Scully, S., Lacey, D. L., et al. (2001) · Development · doi:10.1242/dev.128.16.3105 · Cited by 358
Research works printed but not linked: 1
- Yang J Chai L Gao C Fowles TC Alipio Z 2008 SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood 112(3) 805 13 18487508 PMC2481537 · DOI · Paper page
Cited by
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926
The functions and regulation of the PTEN tumour suppressor: new modes and prospects
Lee, Y.-R., Chen, M., & Pandolfi, P. P. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0015-0 · Cited by 917
PTEN: Multiple Functions in Human Malignant Tumors
Milella, M., Falcone, I., Conciatori, F., Cesta Incani, U., Del Curatolo, A., Inzerilli, N., Nuzzo, C. M. A., Vaccaro, V., Vari, S., Cognetti, F., et al. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00024 · Cited by 463
“have demonstrated that the zincfinger transcription factor sal-like protein 4 (SALL4) represses PTEN transcription by recruiting an epigenetic repressor complex (Mi-2/NuRD) (138).”
BackgroundMechanisms of PTEN loss in cancer: It’s all about diversity
Álvarez-Garcia, V., Tawil, Y., Wise, H. M., & Leslie, N. R. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.02.001 · Cited by 401
The evolving concept of liver cancer stem cells
Nio, K., Yamashita, T., & Kaneko, S. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0572-9 · Cited by 274
“genes, namely, phosphatase and tensin homolog and SALL1, through the epigenetic repressor NuRD complex, which contains histone deacetylases (HDACs) [93].”
BackgroundOncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma
Yong, K. J., Gao, C., Lim, J. S. J., Yan, B., Yang, H., Dimitrov, T., Kawasaki, A., Ong, C. W., Wong, K.-F., Lee, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300297 · Cited by 257
Self-citationTherapeutic Targeting of Cancers with Loss of PTEN Function
Dillon, L., & Miller, T. (2014) · Current Drug Targets · doi:10.2174/1389450114666140106100909 · Cited by 241
“Transcription of PTEN can be repressed by the epigenetic repressor complex Mi-2/NuRD that contains a chromatin-remodeling ATPase and a histone deacetylase (HDAC).”
BackgroundMartelli, A. M., Evangelisti, C., Chappell, W., Abrams, S. L., Bäsecke, J., Stivala, F., Donia, M., Fagone, P., Nicoletti, F., Libra, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.46 · Cited by 204
Functional Antagonism between Sall4 and Plzf Defines Germline Progenitors
Hobbs, R. M., Fagoonee, S., Papa, A., Webster, K., Altruda, F., Nishinakamura, R., Chai, L., & Pandolfi, P. P. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.004 · Cited by 190
“Thus, Sall1 expression follows Plzf induction and formation of the nascent SPC pool in postnatal testis.”
InfluentialSelf-citationDifferential roles of Sall4 isoforms in embryonic stem cell pluripotency
Rao, S., Zhen, S., Roumiantsev, S., McDonald, L. T., Yuan, G.-C., & Orkin, S. H. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00419-10 · Cited by 173
“Differential binding of the two isoforms to different DNA sites has been shown on a small scale by others (26), but the present study is the first genomewide characterization of the binding sites of the individual splice isoforms of a transcription factor.”
BackgroundMcCubrey, J. A., Steelman, L. S., Kempf, C. R., Chappell, W. H., Abrams, S. L., Stivala, F., Malaponte, G., Nicoletti, F., Libra, M., Bäsecke, J., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22647 · Cited by 171
“Increased Rheb expression is associated with a poor prognosis in breast and head and neck cancers (Lu et al., 2010).”
BackgroundNiu, Z., Jin, R., Zhang, Y., & Li, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01200-x · Cited by 170
Non-genomic loss of PTEN function in cancer: not in my genes
Leslie, N. R., & Foti, M. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.12.005 · Cited by 158
A Novel SALL4/OCT4 Transcriptional Feedback Network for Pluripotency of Embryonic Stem Cells
Yang, J., Gao, C., Chai, L., & Ma, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010766 · Cited by 152
“While the detailed mechanism on how SALL4 represses itself still remains unknown, we have shown that SALL4 can recruit the NuRD deacylacation complex.”
BackgroundInfluentialSelf-citationThe transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
Zeng, S. S., Yamashita, T., Kondo, M., Nio, K., Hayashi, T., Hara, Y., Nomura, Y., Yoshida, M., Hayashi, T., Oishi, N., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.024 · Cited by 140
“Taken together, our data suggest a pivotal role for the transcription factor SALL4 in regulating the stemness of HpSC-HCC.”
BackgroundSALL4, the missing link between stem cells, development and cancer
Tatetsu, H., Kong, N. R., Chong, G., Amabile, G., Tenen, D. G., & Chai, L. (2016) · Gene · doi:10.1016/j.gene.2016.02.019 · Cited by 130
Self-citationSALL4, a novel marker for human gastric carcinogenesis and metastasis
Zhang, L., Xu, Z., Xu, X., Zhang, B., Wu, H., Wang, M., Zhang, X., Yang, T., Cai, J., Yan, Y., et al. (2013) · Oncogene · doi:10.1038/onc.2013.495 · Cited by 128
Zic2 Is an Enhancer-Binding Factor Required for Embryonic Stem Cell Specification
Luo, Z., Gao, X., Lin, C., Smith, E. R., Marshall, S. A., Swanson, S. K., Florens, L. A., Washburn, M. P., & Shilatifard, A. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.007 · Cited by 123
Baker, A., Wyatt, D., Bocchetta, M., Li, J., Filipovic, A., Green, A., Peiffer, D. S., Fuqua, S., Miele, L., Albain, K. S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0251-y · Cited by 109
“moter [66] or by mediating upregulation of the microRNA, miR-205, to suppress PTEN translation as seen in BCSCs [67, 68].”
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around
Γκουντάκος, Α., Sartori, G., Falcone, I., Piro, G., Ciuffreda, L., Carbone, C., Tortora, G., Scarpa, A., Bria, E., Milella, M., et al. (2019) · Cancers · doi:10.3390/cancers11081141 · Cited by 115
“At the epigenetic level, SAL-like protein 4 (SALL4) recruits a complex with nucleosome remodeling and histone deacetylate activity (NuRD) at the PTEN locus repressing its transcription [19].”
BackgroundSALL4: An emerging cancer biomarker and target
Zhang, X., Yuan, X., Zhu, W., Qian, H., & Xu, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.037 · Cited by 104
Nio, K., Yamashita, T., Okada, H., Kondo, M., Hayashi, T., Hara, Y., Nomura, Y., Zeng, S. S., Yoshida, M., Hayashi, T., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.009 · Cited by 101
“SALL4 was recently found to directly interact with the epigenetic modulator nucleosome remodeling and histone deacetylase (NuRD) complex [27], thereby altering the histone modifications associated with stemness.”
BackgroundSALL4 is a robust stimulator for the expansion of hematopoietic stem cells
Aguila, J. R., Liao, W., Yang, J., Avila, C., Hagag, N., Senzel, L., & Ma, Y. (2011) · Blood · doi:10.1182/blood-2011-01-333641 · Cited by 84
SALL4 activates TGF-β/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis
Zhang, X., Zhang, P., Shao, M., Zang, X., Zhang, J., Mao, F., Qian, H., & Xu, W. (2018) · Cancer Management and Research · doi:10.2147/cmar.s177373 · Cited by 83
“In liver cancer, SALL4 inhibits PTEN expression by recruiting nucleosome remodeling and deacetylase complex and activates Akt signaling pathway to promote cell proliferation.(15,16) In endometrial cancer, SALL4 promotes cell proliferation, migration, invasion, and drug resistance via the upregulation of c-Myc.”
BackgroundPTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting
Ciuffreda, L., Falcone, I., Incani, U. C., Curatolo, A. D., Conciatori, F., Matteoni, S., Vari, S., Vaccaro, V., Cognetti, F., & Milella, M. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.07.002 · Cited by 90
Ma, C., Wang, F., Han, B., Zhong, X., Si, F., Ye, J., Hsueh, E. C., Robbins, L., Kiefer, S. M., Zhang, Y., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0824-y · Cited by 80
“We thus determined whether SALL1 could alter the expression of other members in the SALL family mediating breast cancer growth suppression [10].”
BackgroundMiller, A., Ralser, M., Kloet, S. L., Loos, R., Nishinakamura, R., Bertone, P., Vermeulen, M., & Hendrich, B. (2016) · Development · doi:10.1242/dev.139113 · Cited by 78
“D E V E LO P M E N T Sall-NuRD interaction is that Sall proteins recruit NuRD to influence transcription of their target genes (Kiefer et al., 2002; Kloet et al., 2015; Lauberth and Rauchman, 2006; Lu et al., 2009; Yuri et al., 2009).”
BackgroundThe multiple layers of non-genetic regulation of PTEN tumour suppressor activity
Correia, N., Gírio, A., Antunes, I., Martins, L. R., & Barata, J. T. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.017 · Cited by 84
“This leads to PTEN inhibition and potentially explains the development of acute myeloid leukaemia (AML) in SALL4 transgenic mice [34].”
BackgroundMasson, G. R., Perišić, O., Burke, J. E., & Williams, R. L. (2015) · Biochemical Journal · doi:10.1042/bj20150931 · Cited by 80
Sall1 Regulates Embryonic Stem Cell Differentiation in Association with Nanog
Karantzali, E., Lekakis, V., Ioannou, M., Hadjimichael, C., Papamatheakis, J., & Kretsovali, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.170050 · Cited by 74
The Therapeutic Potential of PTEN Modulation: Targeting Strategies from Gene to Protein
McLoughlin, N. M., Mueller, C., & Grossmann, T. N. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.10.009 · Cited by 81
Stem Cell Gene SALL4 Suppresses Transcription through Recruitment of DNA Methyltransferases
Yang, J., Corsello, T. R., & Ma, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308734 · Cited by 71
“The SALL4-NuRD complex possesses histone deacetylase (HDAC)(2) activity, which may participate in the repressing effects of SALL4 (14).”
BackgroundResultEpigenetic factors and cardiac development
van Weerd, J. H., Koshiba‐Takeuchi, K., Kwon, C. D., & Takeuchi, J. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr138 · Cited by 93
Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4
He, J., Zhang, W., Zhou, Q., Zhao, T., Song, Y., Chai, L., & Li, Y. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.008 · Cited by 73
Self-citationJeong, H.-W., Cui, W., Yang, Y., Lu, J., He, J., Li, A., Song, D., Guo, Y., Liu, B. H., & Chai, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018372 · Cited by 65
“Alternatively, we have shown that SALL4 represses PTEN expression through recruiting the NuRD complex [30].”
BackgroundInfluentialSelf-citationGao, C., Dimitrov, T., Yong, K. J., Tatetsu, H., Jeong, H.-W., Luo, H. R., Bradner, J. E., Tenen, D. G., & Chai, L. (2013) · Blood · doi:10.1182/blood-2012-04-424275 · Cited by 65
Self-citationA BEN-domain-containing protein associates with heterochromatin and represses transcription
Sathyan, K. M., Shen, Z., Tripathi, V., Prasanth, K. V., & Prasanth, S. G. (2011) · Journal of Cell Science · doi:10.1242/jcs.086603 · Cited by 69
“There is also recent evidence that Sall4 associates with the NuRD and represses transcription of genes (PTEN and SALL1) involved in embryonic stem cell leukemogenesis and kidney development (Lu et al., 2009).”
BackgroundTan, J. L., Li, F., Yeo, J. Z., Yong, K. J., Bassal, M. A., Ng, G. H., Lee, M. Y., Leong, C. Y., Tan, H. K., Wu, C.-S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.022 · Cited by 64
Self-citationChan, A.-L., La, H. M., Legrand, J. M. D., Mäkelä, J.-A., Eichenlaub, M., De Seram, M., Ramialison, M., & Hobbs, R. M. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.08.001 · Cited by 60
“SALL4 can repress genes by recruiting the nucleosome remodeling and deacetylase co-repressor (NuRD) complex (Lauberth and Rauchman, 2006; Lu et al., 2009).”
BackgroundSALL4 is a key transcription regulator in normal human hematopoiesis
Gao, C., Kong, N. R., Li, A., Tatetu, H., Ueno, S., Yang, Y., He, J., Yang, J., Ma, Y., Kao, G. S., et al. (2013) · Transfusion · doi:10.1111/j.1537-2995.2012.03888.x · Cited by 58
Self-citationDNMT3L promotes quiescence in postnatal spermatogonial progenitor cells
Liao, H., Chen, W. S. ‐., Chen, Y.-H., Kao, T.-H., Tseng, Y.-T., Lee, C., Chiu, Y., Lee, P.-L., Lin, Q.-J., Ching, Y.-H., et al. (2014) · Development · doi:10.1242/dev.105130 · Cited by 65
Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy
Liu, Y.-C., Kwon, J., Fabiani, E., Xiao, Z., Liu, Y. V., Follo, M. Y., Liu, J., Huang, H., Gao, C., Liu, J., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2119771 · Cited by 57
Self-citationZinc finger protein SALL4 functions through an AT-rich motif to regulate gene expression
Kong, N. R., Bassal, M. A., Tan, H. K., Kurland, J. V., Yong, K. J., Young, J. J., Yang, Y., Li, F., Lee, J. D., Liu, Y., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108574 · Cited by 56
Self-citationLeighton, G. O., & Williams, D. C. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.10.007 · Cited by 60
SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance
Sun, B., Xu, L., Bi, W., & Ou, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042053 · Cited by 58
“For example, SALL4/MLL/HOXA9 pathway is a crucial regulator of leukemic cell survival and SALL4 plays a critical role in promoting melanoma invasion by interacting with HDAC2.”
BackgroundInfluentialNeff, A. W., King, M. W., & Mescher, A. L. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22554 · Cited by 51
“SALL4 protein is primarily localized to heterochromatin (Bohm et al., 2008) and has been linked to chromatin structure remodeling in ESCs (Yang et al., 2008; Bard et al., 2009; Lu et al., 2009; van den Berg et al., 2010).”
BackgroundBode, D., Yu, L., Tate, P., Pardo, M., & Choudhary, J. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.053207 · Cited by 50
Pioneer and PRDM transcription factors coordinate bivalent epigenetic states to safeguard cell fate
Matsui, S., Granitto, M., Buckley, M., Ludwig, K., Koigi, S., Shiley, J. R., Zacharias, W. J., Mayhew, C. N., Lim, H., & Iwafuchi, M. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.007 · Cited by 50
Yang, L., Liu, L., Gao, H., Pinnamaneni, J. P., Sanagasetti, D., Singh, V. P., Wang, K., Mathison, M., Zhang, Q., Chen, F., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0531-y · Cited by 45
“It is becoming clear that the SALL4 regulatory functions are associated with a variety of chromatin-modifying factors which include DNA methyltransferases (DNMT-1, DNMT-3A, DNMT-3B, DNMT-3L) [15], the nucleosome remodeling and deacetylase (NuRD) complex components HDAC1 /HDAC2 [16], the histone demethylase LSD1/ KDM1A…”
BackgroundSALL4 controls cell fate in response to DNA base composition
Pantier, R., Chhatbar, K., Quante, T., Skourti-Stathaki, K., Cholewa-Waclaw, J., Alston, G., Alexander-Howden, B., Lee, H. Y., Cook, A. G., Spruijt, C. G., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.11.046 · Cited by 45
SALL4 promotes gastric cancer progression through activating CD44 expression
Yuan, X., Zhang, X., Zhang, W., Liang, W., Zhang, P., Shi, H., Zhang, B., Shao, M., Yan, Y., Qian, H., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.69 · Cited by 45
SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway
Liu, C., Wu, H., Li, Y., Shen, L., Yu, R., Yin, H., Sun, T., Sun, C., Zhou, Y., & Du, Z. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2589-3 · Cited by 45
“Hong W and Lauberth SM confirmed that by recruiting Mi-2/Nucleosome Remodeling and Deacetylase (NuRD) complex, SALL4 mediated transcription to impact cell growth [20].”
BackgroundImportance of SALL4 in the development and prognosis of hepatocellular carcinoma
Yin, F., Han, X., Yao, S.-K., Wang, X.-L., & Yang, H.-C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i9.2837 · Cited by 42
Targeting SALL4 by entinostat in lung cancer
Yong, K. J., Li, A., Ou, W.-B., Hong, C. K. Y., Zhao, W., Wang, F., Tatetsu, H., Yan, B., Qi, L., Fletcher, J. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12251 · Cited by 41
“This, however, was not unexpected, as we have reported in our previous studies that one of the main functions of SALL4 is to act as a transcription repressor by interacting with the nucleosome remodeling and deacetylase (NuRD) complex that comprises of HDAC1 and HDAC2 [28].”
BackgroundSelf-citationPagliaroli, L., Porazzi, P., Curtis, A. T., Scopa, C., Mikkers, H. M. M., Freund, C., Daxinger, L., Deliard, S., Welsh, S. A., Offley, S. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26810-x · Cited by 44
SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer
Taguchi, Y., Iwadate, M., & Umeyama, H. (2016) · BMC Medical Genomics · doi:10.1186/s12920-016-0196-3 · Cited by 42
Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis
Nicolè, L., Sanavia, T., Veronese, N., Cappellesso, R., Luchini, C., Dabrilli, P., & Fassina, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14952 · Cited by 39
“In addition, SALL4 complex can control gene accessibility recruiting the epigenetic repressor complex Mi-2/ Nucleosome Remodelling and Deacetylase (NuRD) involved in Phosphatase and TENsin homologue (PTEN) and other SALL-family genes down-regulation [35].”
BackgroundSALL4 promotes glycolysis and chromatin remodeling via modulating HP1α-Glut1 pathway
Kim, J., Xu, S., Xiong, L., Yu, L., Fu, X., & Xu, Y. (2017) · Oncogene · doi:10.1038/onc.2017.265 · Cited by 42
SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis
Yang, J. (2018) · Biomarker Research · doi:10.1186/s40364-017-0115-6 · Cited by 39
“So far the reported SALL4-interacting epigenetic factors include: DNA methyltransferases DNMT-1, −3A, -3B, −3 L, methyl-CpG-binding domain 2 protein (MBD2) [95]; NuRD complex that contains histone deacetylases HDAC1/ 2 [64, 96]; H3K4 methyltransferase MLL1 [74, 97]; H3K79 methyltransferase DOT1L [50, 98]; H3K36 methyl…”
BackgroundSALL Proteins; Common and Antagonistic Roles in Cancer
Álvarez, C., Quiroz, A., Benítez-Riquelme, D., Riffo, E., Castro, A. F., & Pincheira, R. (2021) · Cancers · doi:10.3390/cancers13246292 · Cited by 37
“SALL4 repressed PTEN expression through its interaction with the NuRD complex and favored the development of AML in mice [32].”
BackgroundInfluentialNOTCH and EZH2 collaborate to repress PTEN expression in breast cancer
Pappas, K., Martin, T. C., Wolfe, A. L., Nguyen, C. B., Su, T., Jin, J. J., Hibshoosh, H. H., & Parsons, R. E. (2021) · Communications Biology · doi:10.1038/s42003-021-01825-8 · Cited by 41
Liu, L., Souto, J., Liao, W., Jiang, Y., Li, Y., Nishinakamura, R., Huang, S., Rosengart, T. K., Yang, V. W., Schuster, M. K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.506568 · Cited by 40
SALL4: An Intriguing Therapeutic Target in Cancer Treatment
Moein, S., Tenen, D. G., Amabile, G., & Chai, L. (2022) · Cells · doi:10.3390/cells11162601 · Cited by 35
“Phosphatase and tensin homolog (PTEN) that is an important tumor suppressor gene and blocks Phosphatidylinositol-3-Kinase/Protein Kinase B signaling (PI3K/AKT) is a downstream target of SALL4 [19,20].”
BackgroundSelf-citationEpigenetic control of melanoma cell invasiveness by the stem cell factor SALL4
Diener, J., Baggiolini, A., Pernebrink, M., Dalcher, D., Lerra, L., Cheng, P. F., Varum, S., Häusel, J., Stierli, S., Treier, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25326-8 · Cited by 34
Reddy, S. D. N., Pakala, S. B., Molli, P. R., Sahni, N., Karanam, N. K., Mudvari, P., & Kumar, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348474 · Cited by 37
“(46) reported that stem cell factor SALL4 represses the transcription of PTEN by being recruited onto its promoter (regions 2629 to 2383 bp and 1706 to 1571) in association with theMi-2 NuRD complex, importantly containing MTA1, MTA2, and HDAC2 components, and thereby promotes kidney development and leukemogenesis.”
BackgroundYUE, X., Xiao, L., Yang, Y., Liu, W., ZHANG, K., Shi, G.-Y., Zhou, H., Geng, J., NING, X., Wu, J., et al. (2015) · Neoplasma · doi:10.4149/neo_2015_119 · Cited by 35
“First of all, down-regulation of SALL4 could lead to apoptosis [22], possible through activating some genes, such as PTEN, which are in pro-apoptotic pathway.”
BackgroundInfluentialSelf-citationYamaguchi, Y. L., Tanaka, S., Kumagai, M., Fujimoto, Y., Terabayashi, T., Matsui, Y., & Nishinakamura, R. (2014) · Stem Cells · doi:10.1002/stem.1853 · Cited by 37
Yang, F., Yao, Y., Jiang, Y., Lu, L., Ma, Y., & Dai, W. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.391441 · Cited by 38
“Luciferase Reporter Gene Assays—Expression constructs for the firefly (Photinus pyralis) luciferase gene driven by the SALL4 or OCT4 promoter were described previously (10, 24).”
MethodA novel role for SALL4 during scar-free wound healing in axolotl
Erickson, J. R., Gearhart, M. D., Honson, D. D., Reid, T. A., Gardner, M. K., Moriarity, B. S., & Echeverri, K. (2016) · npj Regenerative Medicine · doi:10.1038/npjregenmed.2016.16 · Cited by 33
The Role of Stem Cell Factor SALL4 in Leukemogenesis
Gao, C., Kong, N. R., & Chai, L. (2011) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v16.i1-2.110 · Cited by 34
Self-citationEpigenetic and Epigenomic Mechanisms Shape Sarcoma and Other Mesenchymal Tumor Pathogenesis
Bennani-Baïti, I. M. (2011) · Epigenomics · doi:10.2217/epi.11.93 · Cited by 34
The Mechanisms Underlying PTEN Loss in Human Tumors Suggest Potential Therapeutic Opportunities
Chang, H., Cai, Z., & Roberts, T. M. (2019) · Biomolecules · doi:10.3390/biom9110713 · Cited by 37
“In addition, SALL4 recruits the Mi-2/Nucleosome Remodeling and Deacetylase (NuRD) complex to the promoter region of PTEN, and represses PTEN transcription via the complex’s histone deacetylase activity [79,80].”
BackgroundAlfieri, R. R., Giovannetti, E., Bonelli, M. A., & Cavazzoni, A. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00170 · Cited by 32
“PTEN inactivation is also a consequence of promoter hypermethylation (15) and reduction of transcription: Sallike protein 4 and SNAIL can bind PTEN promoter mediating its repression through the interaction with the Mi-2/NuRD complex (16), and competition with p53 (17), respectively.”
BackgroundSpalt-like 4 promotes posterior neural fates via repression of pou5f3 family members in Xenopus
Young, J. J., Kjolby, R. A. S., Kong, N. R., Monica, S. D., & Harland, R. M. (2014) · Development · doi:10.1242/dev.099374 · Cited by 31
Self-citationSpina, R., Filocamo, G., Iaccino, E., Scicchitano, S., Lupia, M., Chiarella, E., Mega, T., Bernaudo, F., Pelaggi, D., Mesuraca, M., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1176 · Cited by 29
“This motif recruits the nucleosome remodeling and histone deacetylase (NuRD) complex [3, 4] and is required for the co-repressor function of Friend of GATA (FOG)-1 [5, 6], SALL1 [7] and SALL4 [8].”
BackgroundRole of Ubiquitination in PTEN Cellular Homeostasis and Its Implications in GB Drug Resistance
Qin, X., Ali, S., Liu, L., Li, Y., Liu, X., Zhang, L., & Dong, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01569 · Cited by 31
“Mechanistically, SALL4 recruits the NuRD complex to the PTEN promoter region that causes histone deacetylation in the region, leading to condensed heterochromatin and repressed PTEN expression (92).”
BackgroundSynthetic lethal approaches to target cancers with loss of PTEN function
Ertay, A., Ewing, R. M., & Wang, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.12.015 · Cited by 30
“61 Despite the PTEN mutation frequency being low in breast cancer, the frequency of PTEN promoter methylation is 50% in breast cancer cases.”
Immunoexpression of SALL4 in Wilms Tumors and Developing Kidney
Deisch, J. K., Raisanen, J. M., & Rakheja, D. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9364-0 · Cited by 30
“Constituitive expression of SALL4 represses the activities of the SALL1 and PTEN, both of which are important in renal development [22].”
BackgroundSato, S., Yagi, S., Arai, Y., Hirabayashi, K., Hattori, N., Iwatani, M., Okita, K., Ohgane, J., Tanaka, S., Wakayama, T., et al. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01404.x · Cited by 29
“Sall4 and Suz12 are also involved in histone modifications: Sall4-bound protein complex shows histone deacetylase activity, whereas Suz12 complex acts as a histone methyltransferase (Cao & Zhang 2004; Lu et al. 2009).”
BackgroundTargeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy
Yang, J., Gao, C., Liu, M., Liu, Y., Kwon, J., Qi, J., Tian, X., Stein, A. J., Liu, Y. V., Kong, N. R., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0030 · Cited by 29
Self-citationItou, J., Li, W., Ito, S., Tanaka, S., Matsumoto, Y., Sato, F., & Toi, M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000245 · Cited by 27
“SALL4 binds to genomic DNA with its zinc finger motifs (6) and recruits histone deacetylase complex (7).”
BackgroundChai, L. (2011) · Transfusion · doi:10.1111/j.1537-2995.2011.03371.x · Cited by 29
“The important role of SALL4 in normal hematopoietic stem cells and leukemic stem or initiating cells (LICs) is supported by its interactions with several key players implicated in self-renewal of HSCs and LICs—Wnt/b-catenin, Bmi1,(35,36) and Pten (phosphatase and tensin homolog deletion on chromosome 10).(37) In addit…”
BackgroundSelf-citationThe Urodele Limb Regeneration Blastema: The Cell Potential
Tweedell, K. S. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.115 · Cited by 23
“This stem cell factor represses the transcriptions of genes for both PTEN and SALL4[94].”
BackgroundInfluentialDeng, G., Zhu, L., Huang, F., Nie, W., Huang, W., Xu, H., Zheng, S., Yi, Z., & Wan, T. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s107214 · Cited by 24
“a tumor-suppressor gene that was associated with myeloid leukemia and cystic kidneys.(9) Overexpression of Bmi-1, a oncogenic gene, was positively correlated with Sall4 in acute myeloid leukemia.”
Misawa, K., Misawa, Y., Imai, A., Mochizuki, D., Endo, S., Mima, M., Ishikawa, R., Kawasaki, H., Yamatodani, T., & Kanazawa, T. (2018) · Journal of Cancer · doi:10.7150/jca.23527 · Cited by 26
“SALL4 can also act as a proto-oncogene by regulating the PTEN signaling pathway in glioma cells and myeloid leukemia [45, 46].”
BackgroundSeah, K. S., Loh, J. Y., Nguyen, T. T. T., Tan, H. L., Hutchinson, P. E., Lim, K. K., Dymock, B. W., Long, Y. C., Lee, E. J. D., Shen, H., et al. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.06.029 · Cited by 23
Wang, M., Qiu, R., Gong, Z., Zhao, X., Wang, T., Zhou, L., Lu, W., Shen, B., Zhu, W., & Xu, W. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28764 · Cited by 23
“Moreover, several studies have reported that SALL4 as a transcription factor could repress PTEN expression.(10,11) To further explore the mechanism of miR‐188‐5p in GC cells, we focused on the effect of miR‐188‐5p on SALL4 expression.”
BackgroundFunctional and clinical significance of SALL4 in breast cancer
Dirican, E., & Akkіprіk, M. (2016) · Tumor Biology · doi:10.1007/s13277-016-5150-7 · Cited by 25
“SALL4 inhibits the transcription of PTEN and SALL1 through their interactions with the Mi-2/ NuRD complex [62].”
BackgroundWang, H., Kohashi, K., Yoshizumi, T., Okumura, Y., Tanaka, Y., Shimokawa, M., Iwasaki, T., Aishima, S., Maehara, Y., & Oda, Y. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.03.007 · Cited by 24
“4 which contains histone deacetylase 1 (HDAC1) and histone deacetylase 2 (HDAC2) and represses phosphatase and tensin homolog deleted on chromosome 10 (PTEN) expression [16].”
BackgroundMorin Inhibits Dox-Induced Vascular Inflammation By Regulating PTEN/AKT/NF-κB Pathway
Yu, J., Qi, H., Zhang, H., Zhao, Z., JingZhao, & Nie, Z.-Y. (2022) · Inflammation · doi:10.1007/s10753-022-01701-5 · Cited by 23
Decoding the Pluripotency Network: The Emergence of New Transcription Factors
Lee, K. N., Wong, W. S., & Feng, B. (2013) · Biomedicines · doi:10.3390/biomedicines1010049 · Cited by 23
“Mouse Sall4 encodes two isoform proteins Sall4a and Sall4b [97], in which Sall4a has eight zinc finger domains and Sall4b has only three [98].”
BackgroundInhibition of SALL4 suppresses carcinogenesis of colorectal cancer via regulating Gli1 expression.
Cheng, J., Deng, R., Wu, C., Zhang, P., Wu, K., Shi, L., Liu, X., Bai, J., Deng, M., Gao, J., et al. (2015) · PubMed · Cited by 24
Sall4 overexpression blocks murine hematopoiesis in a dose-dependent manner
Milanovich, S. J., Peterson, J., Allred, J. R., Stelloh, C. T., Rajasekaran, K., Fisher, J. B., Duncan, S. A., Malarkannan, S., & Rao, S. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.09.004 · Cited by 24
“Pten was modestly decreased by both Sall4a and Sall4b, in keeping with previous reports that also showed modest repression of Pten by Sall4 [23].”
ResultEnhancer function regulated by combinations of transcription factors and cofactors
Nakagawa, T., Yoneda, M., Higashi, M., Ohkuma, Y., & Ito, T. (2018) · Genes to Cells · doi:10.1111/gtc.12634 · Cited by 22
“SALL4 represses the expression of target genes, PTEN and SALL1, by recruiting the NuRD complex (Lu et al., 2009).”
BackgroundLKB1IP promotes pathological cardiac hypertrophy by targeting PTEN/Akt signalling pathway
Tian, M., Jiang, X., Li, X., Yang, J., Zhang, C., & Zhang, W. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16199 · Cited by 17
The next new target in leukemia: The embryonic stem cell geneSALL4
Wang, F., Zhao, W., Kong, N. R., Cui, W., & Chai, L. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.969169 · Cited by 20
“SALL4 protein contains the same N-12aa motif,(8,61) and was also found to associate with the NuRD complex and function as a strong transcription repressor.(63) Phosphatase and tensin homolog protein (PTEN) was found to be downregulated in SALL4B transgenic mice.”
BackgroundSelf-citationYakulov, T. A., Raggioli, A., Franz, H., & Kemler, R. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.026914 · Cited by 23
The new advance of SALL4 in cancer: Function, regulation, and implication
Abouelnazar, F. A., Zhang, X., Wang, M., Zhang, J., Yu, D. B., Zang, X., Zhang, J., Li, Y., Xu, J., Yang, Q., et al. (2023) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24927 · Cited by 20
“HDAC HDAC ATM HCC APL Leukemia HCC Repress activity Repress activity Repress activity Repress activity [12] [26] [27] [96]”
BackgroundTanaka, Y., Aishima, S., Kohashi, K., Okumura, Y., Wang, H., Hida, T., Kotoh, K., Shirabe, K., Maehara, Y., Takayanagi, R., et al. (2015) · Histopathology · doi:10.1111/his.12806 · Cited by 19
Role of SALL4 in hematopoiesis
Yang, J., Liao, W., & Ma, Y. (2012) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328353c684 · Cited by 17
“SALL4-immunocomplexes have histone deacetylase activity [39].”
Background
Metadata
- Authors
- Lu, J., Jeong, H., Kong, N., Yang, Y., Carroll, J., Luo, H. R., Silberstein, L. E., YupoMa, & Chai, L.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Chai, Li
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-05-18
- Volume
- 4
- Issue
- 5
- Pages
- e5577
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2679146
- OpenAlex
- W2122638939
- Cited by
- 168
- References
- 51
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 4 · 2023: 12 · 2022: 12 · 2021: 10 · 2020: 6 · 2019: 11 · 2018: 11 · 2017: 11 · 2016: 9 · 2015: 14 · 2014: 10 · 2013: 13 · 2012: 9
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Update notices
- correction (2009-07-27)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- Harvard Stem Cell Institute
- National Heart, Lung, and Blood Institute (R01HL092437)
- National Cancer Institute (K08CA097185)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK063220)
- National Center for Research Resources (P20RR016464)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- SALL4, PTEN, SALL1, NuRD complex, histone deacetylase, transcriptional repression, epigenetic repression, embryonic stem cells, leukemia stem cells, myeloid leukemia, renal cysts, kidney development
- MeSH terms
- Animals, Binding Sites, Cell Line, Histone Deacetylases, Humans, Immunohistochemistry, Magnetic Resonance Imaging, Mice, Transgenic, Promoter Regions, Genetic, Protein Binding, Mass Spectrometry, Transcription Factors, Reverse Transcriptase Polymerase Chain Reaction, Chromatin Immunoprecipitation, Immunoprecipitation, PTEN Phosphohydrolase, Mice, Mi-2 Nucleosome Remodeling and Deacetylase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.